|
1
|
Chen L, Shen X, Chen G, Cao X and Yang J:
Effect of Three-spot seahorse petroleum ether extract on
lipopolysaccharide induced macrophage RAW264.7 inflammatory
cytokine nitric oxide and composition analysis. J Oleo Sci.
64:933–942. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dong D, Zhou NN, Liu RX, Xiong JW, Pan H,
Sun SQ, Ma L and Wang R: Sarsasapogenin-AA13 inhibits LPS-induced
inflammatory responses in macrophage cells in vitro and relieves
dimethylbenzene-induced ear edema in mice. Acta Pharmacol Sin.
38:699–709. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ti D, Hao H, Tong C, Liu J, Dong L, Zheng
J, Zhao Y, Liu H, Fu X and Han W: LPS-preconditioned mesenchymal
stromal cells modify macrophage polarization for resolution of
chronic inflammation via exosome-shuttled let-7b. J Transl Med.
13(308)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schmidt HH, Warner TD, Nakane M,
Förstermann U and Murad F: Regulation and subcellular location of
nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol.
41:615–624. 1992.PubMed/NCBI
|
|
5
|
Tian LX, Tang X, Zhu JY, Zhang W, Tang WQ,
Yan J, Xu X and Liang HP: Corrigendum to ‘Cytochrome P450 1A1
enhances Arginase-1 expression, which reduces LPS-induced mouse
peritonitis by targeting JAK1/STAT6’ [Cell. Immunol 349 (2020)
104047]. Cell Immunol. 351(104084)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Araya AV, Pavez V, Perez C, Gonzalez F,
Columbo A, Aguirre A, Schiattino I and Aguillón JC: Ex vivo
lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2
secretion in whole blood from type 1 diabetes mellitus patients
with or without aggressive periodontitis. Eur Cytokine Netw.
14:128–133. 2003.PubMed/NCBI
|
|
7
|
Chiang SS, Chen LS and Chu CY: Active food
ingredients production from cold pressed processing residues of
Camellia oleifera and Camellia sinensis seeds for regulation of
blood pressure and vascular function. Chemosphere.
267(129267)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim YJ, Hwang SY, Oh ES, Oh S and Han IO:
IL-1beta, an immediate early protein secreted by activated
microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK
and NF-kappaB pathways. J Neurosci Res. 84:1037–1046.
2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nie Z, Xia X, Zhao Y, Zhang S, Zhang Y and
Wang J: JNK selective inhibitor, IQ-1S, protects the mice against
lipopolysaccharides-induced sepsis. Bioorg Med Chem.
30(115945)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lamping N, Dettmer R, Schröder NW, Pfeil
D, Hallatschek W, Burger R and Schumann RR: LPS-binding protein
protects mice from septic shock caused by LPS or gram-negative
bacteria. J Clin Invest. 101:2065–2071. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Shi M, Zeng X, Guo F, Huang R, Feng Y, Ma
L, Zhou L and Fu P: Anti-inflammatory pyranochalcone derivative
attenuates LPS-induced acute kidney injury via inhibiting
TLR4/NF-κB pathway. Molecules. 22(1683)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hou C, Mei Q, Song X, Bao Q, Li X, Wang D
and Shen Y: Mono-macrophage-derived MANF protects against
lipopolysaccharide-induced acute kidney injury via inhibiting
inflammation and renal M1 macrophages. Inflammation. 44:693–703.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gayle DA, Ling Z, Tong C, Landers T,
Lipton JW and Carvey PM: Lipopolysaccharide (LPS)-induced dopamine
cell loss in culture: Roles of tumor necrosis factor-alpha,
interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res.
133:27–35. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Feng T, Yunfeng N, Jinbo Z, Zhipei Z,
Huizhong Z, Li L, Tao J and Yunjie W: Single immunoglobulin IL-1
receptor-related protein attenuates the lipopolysaccharide-induced
inflammatory response in A549 cells. Chem Biol Interact.
183:442–449. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang J, Pan Y, Cao Y, Zhou W and Lu J:
Salidroside regulates the expressions of IL-6 and defensins in
LPS-activated intestinal epithelial cells through NF-κB/MAPK and
STAT3 pathways. Iran J Basic Med Sci. 22:31–37. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pan MH, Lin-Shiau SY and Lin JK:
Comparative studies on the suppression of nitric oxide synthase by
curcumin and its hydrogenated metabolites through down-regulation
of IkappaB kinase and NFkappaB activation in macrophages. Biochem
Pharmacol. 60:1665–1676. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Karin M and Ben-Neriah Y: Phosphorylation
meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev
Immunol. 18:621–623. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chow JC, Young DW, Golenbock DT, Christ WJ
and Gusovsky F: Toll-like receptor-4 mediates
lipopolysaccharide-induced signal transduction. J Biol Chem.
274:10689–10692. 1999.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Faure E, Equils O, Sieling PA, Thomas L,
Zhang FX, Kirschning CJ, Polentarutti N, Muzio M and Arditi M:
Bacterial lipopolysaccharide activates NF-kappaB through toll-like
receptor 4 (TLR-4) in cultured human dermal endothelial cells.
Differential expression of TLR-4 and TLR-2 in endothelial cells. J
Biol Chem. 275:11058–11063. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang G and Ghosh S: Molecular mechanisms
of NF-kappaB activation induced by bacterial lipopolysaccharide
through Toll-like receptors. J Endotoxin Res. 6:453–457.
2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li X, Huang R, Liu K, Li M, Luo H, Cui L,
Huang L and Luo L: Fucoxanthin attenuates LPS-induced acute lung
injury via inhibition of the TLR4/MYD88 signaling axis. Aging
(Albany NY). 12:2655–2667. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hernesniemi J, Lehtimäki T, Rontu R, Islam
MS, Eklund C, Mikkelsson J, Ilveskoski E, Kajander O, Goebeler S,
Viiri LE, Hurme M and Karhunen PJ: Toll-like receptor 4
polymorphism is associated with coronary stenosis but not with the
occurrence of acute or old myocardial infarctions. Scand J Clin Lab
Invest. 66:667–675. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wagner KD and Wagner N: PPARs and
myocardial infarction. Int J Mol Sci. 21(9436)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Daynes RA and Jones DC: Emerging roles of
PPARs in inflammation and immunity. Nat Rev Immunol. 2:748–759.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Ricote M, Li AC, Willson TM, Kelly CJ and
Glass CK: The peroxisome proliferator-activated receptor-gamma is a
negative regulator of macrophage activation. Nature. 391:79–82.
1998.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Jiang C, Ting AT and Seed B: PPAR-gamma
agonists inhibit production of monocyte inflammatory cytokines.
Nature. 391:82–86. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Azuma Y, Shinohara M, Wang PL and Ohura K:
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-10 and IL-12
production by macrophages. Biochem Biophys Res Commun. 283:344–346.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ayza MA, Zewdie KA, Tesfaye BA,
Gebrekirstos ST and Berhe DF: Anti-diabetic effect of telmisartan
through its partial PPARγ-agonistic activity. Diabetes Metab Syndr
Obes. 13:3627–3635. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Paschoal VA, Walenta E, Talukdar S,
Pessentheiner AR, Osborn O, Hah N, Chi TJ, Tye GL, Armando AM,
Evans RM, et al: Positive reinforcing mechanisms between GPR120 and
PPARγ modulate insulin sensitivity. Cell Metab. 31:1173–1188.e5.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cho RL, Yang CC, Tseng HC, Hsiao LD, Lin
CC and Yang CM: Haem oxygenase-1 up-regulation by rosiglitazone via
ROS-dependent Nrf2-antioxidant response elements axis or PPARγ
attenuates LPS-mediated lung inflammation. Br J Pharmacol.
175:3928–3946. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Celinski K, Dworzanski T, Fornal R,
Korolczuk A, Madro A, Brzozowski T and Slomka M: Comparison of
anti-inflammatory properties of peroxisome proliferator-activated
receptor gamma agonists rosiglitazone and troglitazone in
prophylactic treatment of experimental colitis. J Physiol
Pharmacol. 64:587–595. 2013.PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Akimoto H, Negishi A, Oshima S, Wakiyama
H, Okita M, Horii N, Inoue N, Ohshima S and Kobayashi D:
Antidiabetic drugs for the risk of alzheimer disease in patients
with type 2 DM using FAERS. Am J Alzheimers Dis Other Demen.
35(1533317519899546)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wu Y, Xiao W, Pei C, Wang M, Wang X, Huang
D, Wang F and Wang Z: Astragaloside IV alleviates PM2.5-induced
lung injury in rats by modulating TLR4/MyD88/NF-κB signalling
pathway. Int Immunopharmacol. 91(107290)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Islam SU, Lee JH, Shehzad A, Ahn EM, Lee
YM and Lee YS: Decursinol angelate inhibits LPS-induced macrophage
polarization through modulation of the NFκB and MAPK signaling
pathways. Molecules. 23(1880)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
O'Connell RM, Taganov KD, Boldin MP, Cheng
G and Baltimore D: MicroRNA-155 is induced during the macrophage
inflammatory response. Proc Natl Acad Sci USA. 104:1604–1609.
2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hirano S, Zhou Q, Furuyama A and Kanno S:
Differential regulation of IL-1β and IL-6 release in murine
macrophages. Inflammation. 40:1933–1943. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
de la Haba C, Morros A, Martínez P and
Palacio JR: LPS-induced macrophage activation and plasma membrane
fluidity changes are inhibited under oxidative stress. J Membr
Biol. 249:789–800. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zingarelli B and Cook JA: Peroxisome
proliferator-activated receptor-gamma is a new therapeutic target
in sepsis and inflammation. Shock. 23:393–399. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Han X, Wu Y, Yang Q and Cao G: Peroxisome
proliferator-activated receptors in the pathogenesis and therapies
of liver fibrosis. Pharmacol Ther. 222(107791)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
K C S, Kakoty V, Marathe S, Chitkara D and
Taliyan R: Exploring the neuroprotective potential of rosiglitazone
embedded nanocarrier system on streptozotocin induced mice model of
Alzheimer's disease. Neurotox Res. 39:240–255. 2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yi JH, Park SW, Brooks N, Lang BT and
Vemuganti R: PPARgamma agonist rosiglitazone is neuroprotective
after traumatic brain injury via anti-inflammatory and
anti-oxidative mechanisms. Brain Res. 1244:164–172. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Peng Y, Chen L, Qu Y, Wang D and Zhu Y and
Zhu Y: Rosiglitazone prevents autophagy by regulating
Nrf2-antioxidant response element in a rat model of
Lithium-pilocarpine-induced status epilepticus. Neuroscience.
455:212–222. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Arcalis E, Ibl V, Hilscher J, Rademacher
T, Avesani L, Morandini F, Bortesi L, Pezzotti M, Vitale A, Pum D,
et al: Russell-like bodies in plant seeds share common features
with prolamin bodies and occur upon recombinant protein production.
Front Plant Sci. 10(777)2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Song C, Chen J, Li X, Yang R, Cao X, Zhou
L, Zhou Y, Ying H, Zhang Q and Sun Y: Limonin ameliorates dextran
sulfate sodium-induced chronic colitis in mice by inhibiting
PERK-ATF4-CHOP pathway of ER stress and NF-κB signaling. Int
Immunopharmacol. 90(107161)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kaplan J, Cook JA, O'Connor M and
Zingarelli B: Peroxisome proliferator-activated receptor gamma is
required for the inhibitory effect of ciglitazone but not
15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in
human endothelial cells. Shock. 28:722–726. 2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Xia H, Ge Y, Wang F, Ming Y, Wu Z, Wang J,
Sun S, Huang S, Chen M, Xiao W and Yao S: Protectin DX ameliorates
inflammation in sepsis-induced acute lung injury through mediating
PPARγ/NF-κB pathway. Immunol Res. 68:280–288. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Liu WC, Wu CW, Fu MH, Tain YL, Liang CK,
Hung CY, Chen IC, Lee YC, Wu CY and Wu KLH: Maternal high
fructose-induced hippocampal neuroinflammation in the adult female
offspring via PPARγ-NF-κB signaling. J Nutr Biochem.
81(108378)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gonzalez Segura G, Cantelli BA, Peronni K,
Rodrigo Sanches P, Komoto TT, Rizzi E, Beleboni RO, Junior WADS,
Martinez-Rossi NM, Marins M and Fachin AL: Cellular and molecular
response of macrophages THP-1 during Co-culture with inactive
Trichophyton rubrum conidia. J Fungi (Basel).
6(363)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Pires BRB, Silva R, Ferreira GM and
Abdelhay E: NF-kappaB: Two sides of the same coin. Genes (Basel).
9(24)2018.PubMed/NCBI View Article : Google Scholar
|
